中华皮肤科杂志 ›› 2016, Vol. 49 ›› Issue (1): 50-52.

• 研究报道 • 上一篇    下一篇

胫前显性营养不良型大疱性表皮松解症基因突变研究

段妍1,曾抗2,梁燕华3,张启国4,赵小燕5   

  1. 1. 内蒙古自治区人民医院
    2. 广州市南方医科大学南方医院皮肤科
    3. 合肥安徽医科大学第一附属医院皮肤科
    4. 厦门大学附属第一医院皮肤科
    5. 厦门市第一医院皮肤科
  • 收稿日期:2015-04-29 修回日期:2015-06-01 出版日期:2016-01-15 发布日期:2015-12-31
  • 通讯作者: 梁燕华 E-mail:liangdoctor@163.com

Mutation analysis of the COL7A1 gene in pretibial dominant dystrophic epidermolysis bullosa

  • Received:2015-04-29 Revised:2015-06-01 Online:2016-01-15 Published:2015-12-31

摘要:

目的 探讨Ⅶ型胶原基因(COL7A1)在胫前显性营养不良型大疱性表皮松解症(DDEB-Pt)发病中的意义。 方法 收集中国汉族1例DDEB-Pt散发患者及其家庭成员和100例健康对照的外周血标本,用改良盐析法提取外周静脉血中的基因组DNA,通过PCR反应扩增和测序进行序列分析。 结果 测序结果显示,COL7A1基因73号外显子的第6109位碱基鸟嘌呤(G)转化为腺嘌呤(A),使得三螺旋区第2037位密码子由GCT变成ACT,编码氨基酸由甘氨酸(Gly)变为精氨酸(Arg),即c.G6109A(p.Gly2037Arg)甘氨酸替换突变。 结论 COL7A1 基因甘氨酸替换突变为致病性突变,是一新发突变。

Abstract:

Duan Yan, Zeng Kang, Liang Yanhua, Zhang Qiguo, Zhao Xiaoyan Department of Dermatology, Inner Mongolia People′s Hospital, Hohhot 010010, China (Duan Y); Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China (Zeng K, Liang YH); Department of Dermatology, First Affiliated Hospital of Xiamen University, Xiamen 361003, China (Zhang QG, Zhao XY) Corresponding author: Liang Yanhua, Email: liangdoctor @163.com 【Abstract】 Objective To explore the role of type Ⅶ collagen (COL7A1) gene in the pathogenesis of pretibial dominant dystrophic epidermolysis bullosa (DDEB-Pt). Methods Peripheral blood samples were obtained from a sporadic Chinese patient of Han nationality with DDEB-Pt, his parents and 100 healthy human controls. A modified salting-out method was used to extract genomic DNA from the blood samples, and PCR was performed to amplify 118 exons of the COL7A1 gene followed by DNA sequencing. Results A G→A mutation was identified at position 6109 (G6109A) in exon 78 of the COL7A1 gene in this patient, which caused a change from GCT to ACT at codon 2037 in the triple helix region, and resulted in the substitution of glycine (Gly) by arginine (Arg) (p.Gly2037Arg). Conclusion A novel glycine substitution mutation was identified in the COL7A1 gene in the patient with DDEB-Pt, which may be a pathogenic mutation.